Difference between revisions of "Team:Czech Republic/Practices"
| Line 6: | Line 6: | ||
<div class="left"> | <div class="left"> | ||
</html> | </html> | ||
| − | = Engineers = | + | == Engineers == |
[[File:Czech_Republic_IODLecture.png|470px]] | [[File:Czech_Republic_IODLecture.png|470px]] | ||
| Line 16: | Line 16: | ||
</html> | </html> | ||
| − | = Medicine = | + | == Medicine == |
[[File:Czech_Republic_Interview_introduction.png|475px]] | [[File:Czech_Republic_Interview_introduction.png|475px]] | ||
Revision as of 16:25, 15 September 2015
Human Practice
Contents
Outreach strategy
Engineers
Medicine
In order to get a professional opinion on our project and to learn more about cancer and CTCs, we conducted an interview with two cancer specialists, Mgr. Pavel Pitule, Ph.D. and Mgr. Pavel Ostašov, Ph.D. The interview took place at the Biomedical Center of Faculty of Medicine in Pilsen. After introduction of our project idea we discussed some particularly interesting points. This interview was not only helpful and enriching but also led to an agreement to collaborate with the Laboratory of Tumor Biology in the near future.
Mgr. Pavel Pitule Ph.D.
Mgr. Pavel Pitule, Ph.D. is a junior researcher at the Biomedical Center at the Faculty of Medicine in Pilsen. He is the research group leader of Laboratory of Tumor Biology.
Mgr. Pavel Ostašov Ph.D.
Mgr. Pavel Ostašov, Ph.D. is a researcher at the Biomedical Center at the Faculty of Medicine in Pilsen. He is a member of Laboratory of Tumor Biology.
Key output: A suggestion to use a color change instead of the agglutination as an indicator of CTCs' presence. We are definitely going to consider the idea in further research.
Multinational general public vs. biologists GMO survey
Safety
Lab safety
Environmental safety